#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal carcinoma Undifferentiated sarcoma Epilepsy with myoclonic-atonic seizures Arginase deficiency Neuroblastoma recurrent Blastic plasmacytoid dendritic cell neoplasia Ataxia telangiectasia Hereditary haemorrhagic telangiectasia Acquired ATTR amyloidosis Myelodysplastic syndrome with excess blasts Cutaneous T-cell lymphoma stage II Ornithine transcarbamoylase deficiency Cutaneous T-cell lymphoma recurrent Chronic lymphocytic leukaemia refractory Cholangitis sclerosing More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Basic Information Fragile X syndrome – Trials in Disease Ewing’s sarcoma recurrent – Treatment Optic glioma – Diagnostics Myxofibrosarcoma – Basic Information Hereditary motor and sensory neuropathy Medulloblastoma Idiopathic inflammatory myopathy – Treatment Activated PI3 kinase delta syndrome – Trials in Disease Piriformis syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enoxaparin Sodium VX-407 Nelarabine Varenicline Acalabrutinib Fexofenadine Linezolid Temsirolimus Diclofenac Diethylamine Iopamidol Etavopivat Betula Verrucosa (108) Lixudebart Ecopipam Hydrochloride Gimeracil Romosozumab Enx-101 Tryptophan ROC-101 HYDROCHLORIDE Doxycycline More therapies…

    Learn about Your Condition

    Transitional cell carcinoma Monogenic diabetes Nephrolithiasis Bone marrow disorder Hypervolaemia Dilated cardiomyopathy Rhabdoid tumour Biliary tract disorder Oesophagogastroscopy Ovarian cancer recurrent Conjunctivitis Cardiovascular disorder Macular telangiectasia Thrombolysis Marfan's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Two Cisplatin Dosing Schedules with Radiation for Patients with Advanced Head and Neck Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma
    Investigated Drugs:
    • Cisplatin
    Ireland

  • Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pazopanib
    • Spartalizumab
    France

  • Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

    Not yet recruiting

    3 1
    Investigated Drugs:
    • N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
    Austria Belgium Czechia Denmark Finland France +5

  • Study on the Safety of Argon and Oxygen Ventilation for Patients Resuscitated from Cardiac Arrest

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Argon
    • Nitrous Oxide
    • Oxygen
    Italy

  • Study on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Ketamine
    • Sodium Chloride
    Belgium

  • Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to rectum
    • Colorectal cancer
    • Colorectal cancer metastatic
    The Netherlands
Previous Page
1 … 857 858 859 860 861 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!